Citations

Showing 10 of 108104 citations.

An Increased Abundance of Clostridiaceae Characterizes Arthritis in Inflammatory Bowel Disease and Rheumatoid Arthritis: A Cross-sectional Study
Pedrogo, David A. Muñiz , Hillmann, Benjamin , Jeraldo, Patricio , Davis, John M. , Knights, Dan , Nelson, Heidi , Faubion, William A. , Raffals, Laura E. , Kashyap, Purna , Muniz Pedrogo, David A, Taneja, Veena , Raffals, Laura, Jeraldo, Patricio R , Davis, John M , Chen, Jun , Al‐Ghalith, Gabriel A.

Mayo Clinic

Inflammatory Bowel Diseases | October 12, 2018 | Volume: 25 | Issue: 5 | Pages: 902-913

10.1093/ibd/izy318 | PMID 30321331 Get It

Top Ten Tips for Palliative Care Clinicians Caring for Heart Failure Patients
Warraich, Haider J. , Rogers, Joseph G. , Hummel, Ellen K., Mentz, Robert J. , Dunlay, Shannon M. , Mentz, Robert J

Mayo Clinic

Journal of Palliative Medicine | October 12, 2018 | Volume: 21 | Issue: 11 | Pages: 1646-1650

10.1089/jpm.2018.0453 | PMID 30311835 Get It

Abstract Heart failure (HF) is an increasingly prevalent condition with a very high symptom burden. To address challenges faced by palliative care clinicians, we assembled a team of experts to provide high-yield tips for the management of these patients. Prognosis is unpredictable in HF and many patients and physicians overestimate survival. Ejection fraction, notably, is not predictive of prognosis. It is important to have thorough discussions about implantable cardioverter defibrillators in terminally ill HF patients. Diuresis is the mainstay of managing volume overload and dyspnea in these patients and it is important to be aggressive and creative to achieve symptom relief. However, HF patients have a high burden of comorbidities and have many symptoms beyond dyspnea as well. Management in hospice remains challenging for these patients, with a significant risk for readmission to the hospital. Almost a quarter of HF patients discharged to hospice from the hospital die in less than three days.
Taking Transcatheter Mitral Valve Replacement to the Next Level
Rihal, Charanjit S. , Rihal, Charanjit, Guerrero, Mayra , Rihal, Charanjit S.

Mayo Clinic

Circulation: Cardiovascular Interventions | October 12, 2018 | Volume: 11 | Issue: 10 | Pages: No page available

10.1161/circinterventions.118.007369 | PMID 30354644 Get It

Effect of Ascertainment Bias on Estimates of Patient Mortality in Inherited Cardiac Diseases
Nannenberg, Eline A., Rijsingen, Ingrid A.W. van, Zwaag, Paul A. van der , Berg, Maarten P. van den , Tintelen, J. Peter van , Tanck, Michael W.T. , Ackerman, Michael J. , Wilde, Arthur A.M. , Christiaans, Imke , van Tintelen, J Peter , Tanck, Michael , van den Berg, Maarten P

Mayo Clinic

Circulation: Genomic and Precision Medicine | October 12, 2018 | Volume: 11 | Issue: 10 | Pages: No page available

10.1161/circgen.117.001797 | PMID 30354299 Get It

Background: Accurate estimates of survival are indispensable for cardiologists, clinical geneticists, and genetic counselors dealing with families with an inherited cardiac disease. However, a bias towards a more severe disease with a worse outcome in the first publications may not accurately represent the actual survival forecast. We, therefore, evaluated the effect of ascertainment bias on survival in 3 different inherited cardiac diseases (idiopathic ventricular fibrillation, SCN5A overlap syndrome, and arrhythmogenic cardiomyopathy) caused by a founder mutation. Methods: We collected mortality data from mutation-positive subjects with either DPP6 -associated idiopathic ventricular fibrillation, SCN5A overlap syndrome, and PLN -R14del-mediated arrhythmogenic cardiomyopathy >2 to 10 years of ongoing clinical/cascade genetic screening. Results: The median age of survival in DPP6 mutation-positive subjects increased from 44.6 years in the original cohort from 2008 (n=60; 95% CI, 36.8–52.4 years) to 68.2 years in the extended cohort from 2012 (n=235; 95% CI, 64.6–71.7 years; P <0.001). In the SCN5A overlap syndrome, survival increased from 56.1 years in 1999 (n=86; 95% CI, 48.0–64.2 years) to 69.7 years in 2009 (n=197; 95% CI, 61.3–78.2 years; P =0.049). In PLN -R14del positive patients, the median age of survival increased from 63.5 years in 2010 (n=89; 95% CI, 59.1–68.0 years) to 65.2 years in 2012 (n=370; 95% CI, 62.0–68.3 years; P =0.046). Conclusions: The median age of survival in 3 different inherited cardiac diseases with an established pathogenic substrate significantly increased once genetic testing and cascade screening extended, after the first publication that elucidated the discovery of the disease-susceptibility gene/mutation. This underscores the direct and negative influence of ascertainment bias on survival forecasts and the importance of ongoing clinical/genetic follow-up to establish the most accurate disease prognosis for genetically mediated heart diseases.
A Strategy for Risk-adjusted Ranking of Surgeons and Practices Based on Patient-reported Outcomes After Elective Lumbar Surgery
Sivaganesan, Ahilan, Asher, Anthony L. , Bydon, Mohamad , Khan, Inamullah , Kerezoudis, Panagoitis, Foley, Kevin T. , Nian, Hui , Archer, Kristin R. , Devin, Clinton J. , Harrell, Frank E.

Mayo Clinic

Spine | October 12, 2018 | Volume: 44 | Issue: 9 | Pages: 670-677

10.1097/brs.0000000000002894 | PMID 30312268 Get It

Study Design. This study retrospectively analyzes prospectively collected data. Objective. The primary aim of this study is to present a scheme for patient-reported outcome (PRO)-based, risk-adjusted rankings of spine surgeons and sites that perform elective lumbar surgery, using the Quality and Outcomes Database (QOD). Summary of Background Data. There is currently no means of determining which spine surgeons or centers are positive or negative outliers with respect to PROs for elective lumbar surgery. This is a critical gap as we move toward a value-based model of health care in which providers assume more accountability for the effectiveness of their treatments. Methods. Random effects regression models were fit for the following outcomes, with QOD site as a fixed effect but surgeon ID as a random effect: Oswestry Disability Index, EQ-5D, back pain and leg pain, and satisfaction. Hierarchical Bayesian models were also fit for each outcome, with QOD site as a random effect and surgeon as a nested random effect. Results. Our study cohort consists of 8834 patients who underwent surgery by 124 QOD surgeons, for the degenerative lumbar diseases. Nonoverlapping Bayesian credible intervals demonstrate that the variance attributed to QOD site was greater than the nested variance attributed to surgeon ID for the included PROs. Conclusion. This study presents a novel strategy for the risk-adjusted, PRO-based ranking of spine surgeons and practices. This can help identify positive and negative outliers, thereby forming the basis for large-scale quality improvement. Assuming adequate coverage of baseline risk adjustment, the choice of surgeon matters when considering PROs after lumbar surgery; however, the choice of site appears to matter more. Level of Evidence: 3
Unilateral Withdrawal of Life-sustaining Therapy in a Severely Impaired Child
Miller, Kathryn , Coleman, Ryan D. , Eisenberg, Leah , Henriksen, Joan, Lantos, John D. , Weiss, Elliott Mark

Mayo Clinic

Pediatrics | October 12, 2018 | Volume: 142 | Issue: 5 | Pages: No page available

10.1542/peds.2018-0131 | PMID 30315121 Get It

An infant with complex congenital heart disease suffers a prolonged cardiac arrest with minutes of anoxia. He is left with severe brain damage and profound neurologic impairment. He no longer responds to caregivers. Much of the time, he cries and grimaces as if in pain. He has required increasing sedation to control these symptoms. His parents live hours from the hospital and seldom visit. When their infant’s situation is explained to them over the telephone, they request that doctors “do everything to keep him alive.” His bedside caregivers report high levels of moral and psychological distress and frequently discuss J.S.’s “suffering.” An ethics consultation is requested, asking whether it is permissible to withdraw life support despite the parents’ request that therapy continue.
The authors reply
Heiderscheit, Annette, Skaar, Debra J. , Neidecker, Marjorie V. , Chlan, Linda L. , Heiderscheit, Annette

Mayo Clinic

Critical Care Medicine | October 12, 2018 | Volume: 46 | Issue: 11 | Pages: e1085-e1086

10.1097/ccm.0000000000003408 | PMID 30312245 Get It

Commentary on “The stereotypicality of symptomatic and pragmatic argumentation in consultations about palliative systemic treatment for advanced cancer”
Kunneman, Marleen , Gärtner, Fania R. , Hargraves, Ian , Montori, Víctor M.

Mayo Clinic

Journal of Argumentation in Context | October 12, 2018 | Volume: 7 | Issue: 2 | Pages: 204-208

10.1075/jaic.18021.kun Get It